Journal retracted at least 17 papers for self-citation, 14 with same first author

A medical journal in Italy has retracted at least 17 papers by researchers in that country who appear to have been caught in a citation scam. The journal says it also fired three editorial board members for “misconduct” in the matter. 

The retractions, from Acta Medica Mediterranea, occurred in 2017 and 2018, but we’re just finding out about them now; 14 involve roughly the same group of neuroscientists, while three are by different authors from some of the same institutions as the first team. 

The journal last year issued two statements on its website about the cases, which it began investigating in 2018. The first, on Feb. 1, 2019 (we think), declared: 

Continue reading Journal retracted at least 17 papers for self-citation, 14 with same first author

Weekend reads: Advice from an author with 18 retractions; ‘TripAdvisor for peer review’; theft, indictments, and prison

Before we present this week’s Weekend Reads — the first of 2020! — a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Here’s what was happening elsewhere:

Continue reading Weekend reads: Advice from an author with 18 retractions; ‘TripAdvisor for peer review’; theft, indictments, and prison

Prominent cancer researcher loses nine papers, making 10

Andrew Dannenberg (credit Patricia Kuharic)

The Journal of Biological Chemistry (JBC) has retracted nine papers in bulk by a group of cancer researchers in New York led by the prominent scientist Andrew Dannenberg

The work of Dannenberg’s group at Weill Cornell — and the figures in particular — has been the subject of scrutiny on PubPeer for more than two years. 

The group also lost an article more than a decade ago in The Lancet, bringing their total so far to 10. Cancer Discovery subjected a paper to an expression of concern in August. Much of the tainted work was funded by grants from the U.S. government, as well as from funding authorities in other countries.  

According to the notice for 2014’s “p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression“:

Continue reading Prominent cancer researcher loses nine papers, making 10

Nobel winner retracts paper from Science

Frances Arnold

A Caltech researcher who shared the 2018 Nobel Prize in Chemistry has retracted a 2019 paper after being unable to replicate the results.

Frances Arnold, who won half of the 2018 prize for her work on the evolution of enzymes, tweeted the news earlier today:

Continue reading Nobel winner retracts paper from Science

PLOS ONE retracts a paper first flagged in 2015 — and breaks the 100 retraction barrier for 2019

A team of researchers in Saudi Arabia, led by an ex-pat from Johns Hopkins University, has lost three papers for problems with the images in their articles. 

The three retractions pushed the journal — which has become a “major retraction engine” for reasons we explain here and hereover 100 for 2019.

In December, PLOS ONE retrcated three papers by the group, led by Michael DeNiro, of the King Khaled Eye Specialist Hospital in Riyadh. First, the journal retracted a 2011 article, “Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy,” the co-authors were Falah H Al-Mohanna and Futwan A Al-Mohanna. According to the retraction notice

Continue reading PLOS ONE retracts a paper first flagged in 2015 — and breaks the 100 retraction barrier for 2019